On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
The peptide market has seen an influx of new vendors over the past 24 months, many with minimal track records and questionable quality standards
Peptides are molecules which enhance cellular function on many levels
These preclinical results prompted off-label use in humans, primarily through compounding pharmacies and peptide clinics
This comprehensive analysis aimed to elucidate the neurochemical changes associated with PCPA-induced insomnia and the potential therapeutic effects of our treatment
Since muscle tissue has a greater blood supply, it can hold more of the nutrients injected into it, helping to provide maximum benefit and results